DADATA·ANALYSIS
FREE
company · cik 1668243

UroGen Pharma Ltd.

URGNNasdaqSIC 2834public
financials · annual · usd2026
Revenue$109.8M
Net income-$153.5M
Total assets$200.5M
Total liabilities$305.9M
Equity-$105.5M
LT debt$122.2M
Operating cash-$162.4M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1